BiotechTube
Home/TearSolutions/Colin M. Rolph
CM

Colin M. Rolph

Chief Financial Officer

TearSolutions

Therapeutic Areas

OphthalmologyOcular Surface Disease

TearSolutions Pipeline

DrugIndicationPhase
LacripepOcular Surface Disease / Dry Eye Disease (Primary Sjögren's Syndrome)Phase 2

Leadership Team at TearSolutions

AC
Anil C. Asrani
President / CEO
GW
Gordon W. Laurie, PhD FARVO
Chief Scientific Officer / Co-founder
JN
James N. Cook
Chief Development Officer
MG
Marc G. Odrich, MD
Chief Medical Officer / Medical Director
View full TearSolutions profile